Molecular mechanisms of glucocorticoids action: implications for treatment of rhinosinusitis and nasal polyposis

被引:26
|
作者
Grzanka, Alicja [1 ]
Misiolek, Maciej [2 ]
Golusinski, Wojciech [3 ]
Jarzab, Jerzy [1 ]
机构
[1] Med Univ Silesia, Clin Dept Internal Dis Dermatol & Allergol, PL-41800 Katowice, Poland
[2] Med Univ Silesia, Clin Dept Laryngol, PL-41800 Katowice, Poland
[3] Poznan Univ Med Sci, Greater Poland Canc Ctr, Dept Head & Neck Surg & Laryngol Oncol, Poznan, Poland
关键词
Glucocorticoids; Nongenomic and genomic action; Nasal polyps; Rhinitis; FLUTICASONE PROPIONATE; IN-VITRO; RECEPTOR; RHINITIS; UPDATE; DEXAMETHASONE; MANAGEMENT; SPRAY;
D O I
10.1007/s00405-010-1330-z
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Intra-nasal glucocorticoids are the most effective drugs available for rhinosinusitis and nasal polyposis treatment. Their effectiveness depends on many factors and not all of them have been well recognized so far. The authors present the basic information on molecular mechanisms of glucocorticoid action, direct and indirect effects of glucocorticoids on transcription of genes encoding inflammatory mediators. They focus on recently proved nongenomic mechanisms which appear quickly, from several seconds to minutes after glucocorticoid administration and discuss clinical implications resulting from this knowledge. Discovery of nongenomic glucocorticoid actions allows for better use of these drugs in clinical practice.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 50 条
  • [1] Molecular mechanisms of glucocorticoids action: implications for treatment of rhinosinusitis and nasal polyposis
    Alicja Grzanka
    Maciej Misiołek
    Wojciech Golusiński
    Jerzy Jarząb
    European Archives of Oto-Rhino-Laryngology, 2011, 268 : 247 - 253
  • [2] Dupilumab for the treatment of chronic rhinosinusitis with nasal polyposis
    Fokkens, Wytske
    van der Lans, Rik
    Reitsma, Sietze
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (05) : 575 - 585
  • [3] OMALIZUMAB AS A TREATMENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
    Brunet, B. A.
    Marshall, G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (02) : 636 - 636
  • [4] Omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis
    Camilo Martinez-Alonso, Jose
    REVISTA DE LA SOCIEDAD OTORRINOLARINGOLOGICA DE CASTILLA Y LEON CANTABRIA Y LA RIOJA, 2015, 6 : 114 - 118
  • [5] Hyaluronan in the Treatment of Chronic Rhinosinusitis with Nasal Polyposis
    Cassandro E.
    Chiarella G.
    Cavaliere M.
    Sequino G.
    Cassandro C.
    Prasad S.C.
    Scarpa A.
    Iemma M.
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2015, 67 (3) : 299 - 307
  • [6] Dupilumab in the treatment of chronic rhinosinusitis with nasal polyposis
    Boyle, John V.
    Lam, Kent K.
    Han, Joseph K.
    IMMUNOTHERAPY, 2020, 12 (02) : 111 - 121
  • [7] Antileukotrienes in rhinosinusitis and nasal polyposis
    Alobid, Isam
    Cardelus, Sara
    Picado, Cesar
    Mullol, Joaquim
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2008, 4 (03) : 331 - 337
  • [8] Biologics for the Treatment of Allergic Rhinitis, Chronic Rhinosinusitis, and Nasal Polyposis
    Eschenbacher, William
    Straesser, Matthew
    Knoeddler, Alice
    Li, Rung-chi
    Borish, Larry
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2020, 40 (04) : 539 - 547
  • [9] Molecular Mechanisms of Nasal Epithelium in Rhinitis and Rhinosinusitis
    Toppila-Salmi, Sanna
    van Drunen, Cornelis M.
    Fokkens, Wytske J.
    Golebski, Korneliuz
    Mattila, Pirkko
    Joenvaara, Sakari
    Renkonen, Jutta
    Renkonen, Risto
    CURRENT ALLERGY AND ASTHMA REPORTS, 2015, 15 (02) : 1 - 9
  • [10] Molecular Mechanisms of Nasal Epithelium in Rhinitis and Rhinosinusitis
    Sanna Toppila-Salmi
    Cornelis M. van Drunen
    Wytske J. Fokkens
    Korneliuz Golebski
    Pirkko Mattila
    Sakari Joenvaara
    Jutta Renkonen
    Risto Renkonen
    Current Allergy and Asthma Reports, 2015, 15